Rocket


News + Filings
Transactions


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Lee Gary K. Create: Alert

All | News | Filings
Date FiledTypeDescription
02/28/2023 4 Lee Gary K. (Chief Scientific Officer) has filed a Form 4 on Lyell Immunopharma, Inc.
Txns: Granted 600,000 options to buy @ $2.13, valued at $1.3M
02/14/2022 4 Lee Gary K. (Chief Scientific Officer) has filed a Form 4 on Lyell Immunopharma, Inc.
Txns: Granted 800,000 options to buy @ $6.04, valued at $4.8M

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy